Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019

J Thromb Thrombolysis. 2020 Nov;50(4):1012-1014. doi: 10.1007/s11239-020-02248-8. Epub 2020 Aug 11.

Authors

Yoshihiko Ogawa¹, Toshihiko Nagata², Taisuke Akiyama², Koji Nishida³, Junji Kumasawa², Michihiko Kohno², Hisakazu Kohata², Iwao Gohma³

Affiliations

¹ Department of Infectious Diseases, Sakai City Medical Center, Ebaraji 1-1-1, Sakai, Osaka, 593-8304, Japan. hikoichi.ogw@gmail.com.
² Department of Critical Care Medicine, Sakai City Medical Center, Ebaraji 1-1-1, Sakai, Osaka, 593-8304, Japan.
³ Department of Respiratory Medicine, Sakai City Medical Center, Ebaraji 1-1-1, Sakai, Osaka, 593-8304, Japan.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anticoagulants / administration & dosage
Anticoagulants / adverse effects*
Antithrombins / therapeutic use*
Arginine / analogs & derivatives
Betacoronavirus / pathogenicity
Blood Coagulation / drug effects*
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / diagnosis
Coronavirus Infections / therapy*
Coronavirus Infections / virology
Heparin / administration & dosage
Heparin / adverse effects*
Host-Pathogen Interactions
Humans
Male
Pandemics
Pipecolic Acids / therapeutic use*
Pneumonia, Viral / complications
Pneumonia, Viral / diagnosis
Pneumonia, Viral / therapy*
Pneumonia, Viral / virology
Pulmonary Embolism / blood
Pulmonary Embolism / diagnosis
Pulmonary Embolism / drug therapy*
Pulmonary Embolism / virology
SARS-CoV-2
Sulfonamides
Thrombocytopenia / blood
Thrombocytopenia / chemically induced
Thrombocytopenia / diagnosis
Thrombocytopenia / drug therapy*
Treatment Outcome

Substances

Anticoagulants
Antithrombins
Pipecolic Acids
Sulfonamides
Heparin
Arginine
argatroban